P

Premier Specialists Pty Ltd. | Kogarah, Australia

Research site

(Unclaimed)

Location

17 Kensington Street, Kogarah, New South Wales, Australia

Site insights

Top conditions

Top treatments

PF-06651600

Ruxolitinib

PF-06700841

Etrasimod

BTX 1204

PLACEBO-CONTROLLED SAFETY STUDY OF RITLECITINIB

Povorcitinib

PF 06826647

PF-06650833

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 13 total trials

A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Prurigo Nodularis (PN) (TRuE-PN2)

The purpose of this study is to evaluate the safety and tolerability of Ruxolitinib cream in participants with Prurigo Nodularis (PN).

Active, not recruiting

Prurigo Nodularis

Drug: Ruxolitinib Cream

Drug: Vehicle Cream

Locations recently updated

A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2)

The purpose of this study is to evaluate effect of povorcitinib on itch and skin lesions in participants with prurigo nodularis.

Enrolling

Prurigo Nodularis

Drug: Placebo

Drug: Povorcitinib

Status recently updated

A Study to Evaluate the Efficacy, and Safety Study of Ruxolitinib Cream in Adults With Moderate Atopic Dermatitis (TRuE-AD4)

This study is being conducted to establish the efficacy of ruxolitinib cream in participants with moderate AD who had an inadequate response to, or a...

Enrolling

Active, not recruiting

Atopic Dermatitis

Drug: Ruxolitinib Cream

Drug: Vehicle Cream

Long-Term PF-06651600 for the Treatment of Alopecia Areata (ALLEGRO-LT)

This is a global Phase 3 study to evaluate the safety and effectiveness of an investigational study drug (called PF-06651600) in adults and adolescen...

Active, not recruiting

Alopecia Areata

Biological: Meningococcal (groups A, C, W-135 and Y [ACWY]) oligosaccharide diphtheria CRM197 conjugate vaccine

Biological: Tetanus and diphtheria toxoids and acellular pertussis (Tdap) vaccine